{
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 94,
    "total_characters": 25286
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "Flublok contains recombinant Ha proteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response, measured by hem agglutination inhibition (HI) anti bod",
      "relevance_explanation": "This quote establishes that Flublok (a BEVS-produced recombinant HA vaccine) induces a humoral immune response, which is a prerequisite for the claim about antibody induction."
    },
    {
      "id": 2,
      "quote": "Flublok is a vaccine indicated for activ",
      "relevance_explanation": "This quote identifies Flublok as a vaccine, supporting the context that the document is discussing a BEVS-produced recombinant HA antigen vaccine."
    }
  ],
  "model_used": "gpt-4.1"
}